Nov 16, 2017

Marlin & Associates wins “Professional Services (B-to-B) Deal of the Year Award” from The M&A Advisor

Award, In the News, Market Update 0 Comments

Pleased to announce that this week, The M&A Advisor, a conference producer and newsletter publisher serving the middle-market finance industry, recognized us as the winner of the “Professional Services (B-to-B) Deal of the Year Award” (Over $100MM) for advising BillingTree, the leading provider of integrated payment solutions to the healthcare and financial services industries in a majority recapitalization led by Parthenon Capital Partners in partnership with BillingTree’s senior management team. We are always pleased when our hard work is recognized by our peers. Please find more of our awards here.

Nov 15, 2017

Is Capital Markets Tech the Forgotten Stepchild of Fintech? Our November 2017 Fintech M&A report

Fintech, Market Update, Newsletter 0 Comments

Dear Clients and Friends, Our latest Fintech m&a report can be found here. It highlights m&a trends and transactions in the seven segments of the Fintech world that we follow, and sometimes lead. Please click here for our November Fintech Market Update. There is a revolution going on in many areas of Fintech. It’s obvious to anyone who uses their smart phone for banking, uses Alipay, PayPal, or Venmo to make online payments; uses ApplePay or LevelUp for mobile purchases; knows about crypto-currencies such as Bitcoin and Etherium; or about Kabbage, OnDeck or others doing business lending; or about our client, BillingTree, for managing b2b…

Read More

Nov 7, 2017

Tax Policy, Gridlock, and Infotech. Our November 2017 Market Update

Uncategorized 0 Comments

Dear Clients and Friends, Our latest report is found here. It contains an update on the m&a deals, values, and trends in the dozen+ segments of the information technology industry that we follow and sometimes lead. This week the news is filled with conflicting reports about the purported benefits and drawbacks of the GOP proposal to reform the US income tax code. Predictably, people who may benefit tend to like the proposal (e.g. banks, large multi-nationals, and many in the top 10%); and those who could be harmed denigrate it (e.g. the housing industry and people in high-tax states). Many middle-income Americans are confused;…

Read More

Nov 2, 2017

The “First Mover Disadvantage”- Ken Marlin with Tabb Forum’s Terry Roche.

Market Update, Uncategorized 0 Comments

Our Founder, Ken Marlin, is the keynote speaker at The Tabb Group’s Fintech Festival being held at the New York Hilton on November 2. In advance of the forum, Tabb’s Terry Roche interviewed Ken. A link to video of Part III of the interview can be found here. (Parts I and II were listed earlier this month and can be found here and here.) In Part III of the Interview, Terry and Ken talk about new technology models in Capital Markets and the “first mover” disadvantage. For more on the Tabb Group FinTech Festival please click here. For some of our…

Read More

Oct 31, 2017

Is Bioelectronic Medicine the Next, Next Thing for Big Pharma?

Healthcare IT, Healthcare Newsletter 0 Comments

Dear Clients and Friends, Please click here for our October HIT Market Update. According to PhRMS, it takes 10 years and $2.6 billion to bring a drug to market and only two out of ten approved medications produce revenues that exceed their R&D costs. Many expect the picture to worsen in the coming years. Perhaps it is time to invest less in chemical engineering and pay more attention to bioelectronic medicines. The vision for bioelectronic medicines is one of miniature, implantable devices that can be attached to individual peripheral nerves. The nervous system is essentially the body’s electrical and communication systems that…

Read More

Back to Top